86 completed, 37 unknown, 21 recruiting, 14 not yet recruiting. 176 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 176 | Completed 86, Unknown 37, Recruiting 21, Not yet recruiting 14, Terminated 9, Withdrawn 5, Active not recruiting 4 |
Follow Breast Cancer: new trials by email Literature Review of Breast Cancer trials Research Report on Breast Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer Blood samples for PK, Questionnaire - Abemaciclib, Abemaciclib-related Diarrhea | Phase 4 | Not yet recruiting | Poitiers University Hospital | 235 | 2026-09-01 | 2026-07-21 |
| Innovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients. Experimental - Elderly, Breast Cancer | Phase 4 | Not yet recruiting | Gustave Roussy, Cancer Campus, Grand Paris | 794 | 2026-09-01 | 2026-09-03 |
| Adherence and Safety of Ribociclib Plus Aromatase Inhibitors in Patients With Early Stage, HR+ and HER2- Breast Cancer Adherence package consisting of additional education and adherence reminders - Breast Cancer, Adherence, Medication | Phase 4 | Not yet recruiting | Institute of Oncology Ljubljana | 90 | 2026-09-01 | 2026-06-05 |
| Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors Tirzepatide - Obesity (Disorder), Breast Cancer | Phase 4 | Recruiting | Weill Medical College of Cornell University | 30 | 2026-06-08 | 2026-07-22 |
| Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP Trastuzumab Rezetecan - Breast Cancer, HER2-positive Breast Cancer | Phase 4 | Not yet recruiting | The First Affiliated Hospital with Nanjing Medical University | 59 | 2026-05-31 | 2026-05-15 |
| Impact of Propranolol Strategies on Myocardial Injury After Breast Cancer Surgery propranolol, Usual Care - Breast Cancer, Myocardial Injury After Noncardiac Surgery (MINS) | Phase 4 | Not yet recruiting | Chang-Ik Yoon | 100 | 2026-05-26 | 2026-05-15 |
| Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients Rosuvastatin 20 mg/day, Placebo tablets similar to rosuvastatin 20mg tablets - Anthracycline-induced Cardiac Toxicity, Breast Cancer | Phase 4 | Not yet recruiting | Shiraz University of Medical Sciences | 400 | 2026-02-01 | 2025-12-10 |
| Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC Dapagliflozin (5-10 mg daily) - SGLT2 Inhibitor Therapy, Sitagliptin (DPP4 inhibitor), Standard Care (in control arm) - Breast Cancer | Phase 4 | Recruiting | Tanta University | 150 | 2026-02-01 | 2026-10-15 |
| Hand and Foot Bath for Taxane-Induced Peripheral Neurotoxicity Traditional Chinese medicine (TCM) hand and foot baths, Methylcobalamin (methylB12) - Breast Cancer | Phase 4 | Not yet recruiting | Peking University Cancer Hospital & Institute | 78 | 2026-02-01 | 2026-01-20 |
| Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol Modification to Pre-operative Order Set - Breast Cancer | Phase 4 | Recruiting | Memorial Sloan Kettering Cancer Center | 1896 | 2025-12-16 | 2025-12-30 |
| A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement Tissue Expander (TE), Vancomycin and Gentamicin, Stimulan Rapid Cure - Breast Cancer | Phase 4 | Recruiting | Memorial Sloan Kettering Cancer Center | 392 | 2025-10-21 | 2026-07-10 |
| Randomized Controlled Clinical Study on the Reduction of Tumor Marker Levels in Breast Cancer Patients by Huaier Granules Huaier granule - Breast Cancer | Phase 4 | Not yet recruiting | Fudan University | 232 | 2025-09-01 | 2025-09-08 |
| A Randomized, Self-controlled Post-marketing Clinical Study on the Comparison of Shengbai Oral Liquid and Leucogen Tablets in the Treatment of Moderate Neutropenia Caused by Anti-tumor Drugs in Breast Cancer Patients Group A, Group B - Breast Cancer, Bone Marrow Suppression | Phase 4 | Recruiting | Hongxia Wang | 60 | 2025-08-06 | 2026-05-11 |
| Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer lobaplatin, carboplatin, Docetaxel or albumin paclitaxel - Breast Cancer | Phase 4 | Not yet recruiting | Shandong Cancer Hospital and Institute | 468 | 2025-08-01 | 2025-07-30 |
| A Study of Revaree Plus in People With Breast Cancer Revaree Plus - Breast Cancer, Stage 0 Breast Cancer | Phase 4 | Recruiting | Memorial Sloan Kettering Cancer Center | 60 | 2025-06-20 | 2026-02-06 |
| Neoadjuvant Chemotherapy with or Without Talniflumate for the Treatment of Breast Cancer Talniflumate - Breast Cancer | Phase 4 | Not yet recruiting | Shandong University | 200 | 2025-06-01 | 2025-01-16 |
| Viscum Album for TNBC on Adjuvant Pembrolizumab viscum album - Breast Cancer, Triple Negative Breast Cancer | Phase 4 | Recruiting | Ilsan Cha hospital | 40 | 2025-03-19 | 2025-04-10 |
| Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian Patients Trastuzumab deruxtecan - BREAST CANCER | Phase 4 | Active not recruiting | AstraZeneca | 100 | 2025-01-02 | 2026-09-11 |
| Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies Dexmedetomidine, Liposomal bupivacaine - Breast Cancer | Phase 4 | Recruiting | United States Naval Medical Center, Portsmouth | 200 | 2024-10-15 | 2024-11-19 |
| An Exploratory Clinical Study of CDK4/6i Dalpiciclib Combined With AI Neoadjuvant Therapy for Stage II-III HR+/HER2- Breast Cancer Dalpiciclib - Breast Cancer | Phase 4 | Not yet recruiting | Jiangsu Famous Medical Technology Co., Ltd. | 30 | 2024-10-15 | 2024-09-25 |
Showing 20 of 176. Sign in to see all of them.
Breast Neoplasms (176) · Pain, Postoperative (10) · Cardiotoxicity (5) · Ovarian Neoplasms (5) · Neoplasms (4) · Osteoporosis (4) · Pain (4) · Prostatic Neoplasms (4) · Bone Diseases, Metabolic (3) · Colorectal Neoplasms (3) · Neoplasm Metastasis (3) · Neutropenia (3) · Carcinoma, Intraductal, Noninfiltrating (2) · Esophageal Neoplasms (2) · Lung Neoplasms (2)
Neoplasms by Site (176) · Skin Diseases (176) · Skin and Connective Tissue Diseases (176) · Breast Diseases (175) · Neoplasms (172) · Pathological Conditions, Signs and Symptoms (31) · Pathologic Processes (23) · Signs and Symptoms (18) · Neurologic Manifestations (13) · Genital Diseases (12) · Urogenital Diseases (12) · Urogenital Neoplasms (11) · Pain (9) · Postoperative Complications (9) · Female Urogenital Diseases (8)
Docetaxel (14) · Cyclophosphamide (12) · Letrozole (9) · Trastuzumab (9) · Paclitaxel (6) · Saline Solution (6) · pertuzumab (6) · Anastrozole (5) · Capecitabine (5) · Carboplatin (5) · Dexmedetomidine (5) · Epirubicin (5) · Zoledronic Acid (5) · pegfilgrastim (5) · Bevacizumab (4)
Ottawa Hospital Research Institute (12) · Hoffmann-La Roche (10) · AstraZeneca (5) · Memorial Sloan Kettering Cancer Center (4) · Novartis Pharmaceuticals (4) · Second Affiliated Hospital, Zhejiang University, School of Medicine (4) · Weill Medical College of Cornell University (3) · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. (2) · Cancer Center of Irvine (2) · Hospital Clinic of Barcelona (2) · Institut Claudius Regaud (2) · Institut fuer Frauengesundheit (2) · National Taiwan University Hospital (2) · Novartis (2) · Shandong Cancer Hospital and Institute (2)
United States (51) · China (29) · Canada (15) · France (8) · Spain (8) · India (7) · Egypt (6) · Germany (6) · Denmark (5) · South Korea (5) · Belgium (4) · Italy (4) · United Kingdom (4) · Poland (3) · Australia (2)
Marie-France Savard, MD (3) · Andreas Schneeweiss, MD, Prof. (2) · Anil Kukreja, MD (2) · Caigang Liu, M.D., Ph.D. (2) · Kenneth M Tokita, MD (2) · Mark Clemons, MD (2) · Richard B Wilder, MD (2) · Sharon McGee, MD (2) · Aijun Sun, PH.D M.D (1) · Alfonso Frigerio, Dr (1) · Alice Shapiro, PhD (1) · Arash Kardan, MD (1)
PMID 25071111, PMID 26348120, PMID 26438146, PMID 27432417, PMID 38979716, PMID 12457622, PMID 15135924, PMID 16418496, PMID 17131349, PMID 18165618, PMID 18572266, PMID 19786984, PMID 20118030, PMID 20939928, PMID 21073761, PMID 21518565, PMID 21600374, PMID 22114900, PMID 22350731, PMID 22619725, PMID 22706835, PMID 22894640, PMID 23001082, PMID 23511909, PMID 24534856, PMID 24777126, PMID 24801171, PMID 25171229, PMID 25442036, PMID 25555830, PMID 26947961, PMID 26952040, PMID 26994459, PMID 27343991, PMID 27900987, PMID 29291932, PMID 30040817, PMID 30099602, PMID 30119663, PMID 30264707, PMID 30721699, PMID 31297647, PMID 31651976, PMID 31754048, PMID 32554133, PMID 32677982, PMID 33078318, PMID 33705788, PMID 33985854, PMID 34068083
2005 (2), 2025 (2), 2009 (1), 2014 (1), 2017 (1), 2019 (1), KL2TR002385 (1), R01CA140338 (1), R01CA258898 (1), U01CA116892 (1)